Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FREDUN PHARMA vs IND SWIFT LA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FREDUN PHARMA IND SWIFT LA FREDUN PHARMA/
IND SWIFT LA
 
P/E (TTM) x 18.0 2.3 776.4% View Chart
P/BV x 2.7 0.6 410.6% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FREDUN PHARMA   IND SWIFT LA
EQUITY SHARE DATA
    FREDUN PHARMA
Mar-24
IND SWIFT LA
Mar-24
FREDUN PHARMA/
IND SWIFT LA
5-Yr Chart
Click to enlarge
High Rs1,249123 1,012.2%   
Low Rs65056 1,159.3%   
Sales per share (Unadj.) Rs740.8216.8 341.7%  
Earnings per share (Unadj.) Rs33.271.3 46.6%  
Cash flow per share (Unadj.) Rs41.380.3 51.4%  
Dividends per share (Unadj.) Rs0.700-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs255.1157.6 161.8%  
Shares outstanding (eoy) m4.7059.09 8.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.4 309.6%   
Avg P/E ratio x28.61.3 2,270.0%  
P/CF ratio (eoy) x23.01.1 2,057.3%  
Price / Book Value ratio x3.70.6 653.8%  
Dividend payout %2.10-   
Avg Mkt Cap Rs m4,4625,302 84.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1251,415 8.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,48212,809 27.2%  
Other income Rs m9454 2.0%   
Total revenues Rs m3,49113,263 26.3%   
Gross profit Rs m3806,408 5.9%  
Depreciation Rs m38533 7.1%   
Interest Rs m137511 26.7%   
Profit before tax Rs m2155,818 3.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m581,603 3.6%   
Profit after tax Rs m1564,215 3.7%  
Gross profit margin %10.950.0 21.8%  
Effective tax rate %27.227.6 98.6%   
Net profit margin %4.532.9 13.6%  
BALANCE SHEET DATA
Current assets Rs m2,5726,611 38.9%   
Current liabilities Rs m1,6682,213 75.4%   
Net working cap to sales %26.034.3 75.6%  
Current ratio x1.53.0 51.6%  
Inventory Days Days5132 3.7%  
Debtors Days Days680482 141.1%  
Net fixed assets Rs m5044,721 10.7%   
Share capital Rs m47591 8.0%   
"Free" reserves Rs m1,1528,724 13.2%   
Net worth Rs m1,1999,315 12.9%   
Long term debt Rs m128112 114.6%   
Total assets Rs m3,07611,333 27.1%  
Interest coverage x2.612.4 20.8%   
Debt to equity ratio x0.10 890.6%  
Sales to assets ratio x1.11.1 100.1%   
Return on assets %9.541.7 22.8%  
Return on equity %13.045.2 28.8%  
Return on capital %26.567.1 39.4%  
Exports to sales %22.30-   
Imports to sales %0.30-   
Exports (fob) Rs m777NA-   
Imports (cif) Rs m9NA-   
Fx inflow Rs m7770-   
Fx outflow Rs m90-   
Net fx Rs m7680-   
CASH FLOW
From Operations Rs m-4-1,631 0.3%  
From Investments Rs m-76-1,043 7.3%  
From Financial Activity Rs m606,807 0.9%  
Net Cashflow Rs m-214,137 -0.5%  

Share Holding

Indian Promoters % 48.9 42.0 116.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 1.6 100.0%  
FIIs % 0.0 0.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.1 58.0 88.1%  
Shareholders   8,018 28,883 27.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FREDUN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on FREDUN PHARMA vs IND SWIFT LA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

FREDUN PHARMA vs IND SWIFT LA Share Price Performance

Period FREDUN PHARMA IND SWIFT LA S&P BSE HEALTHCARE
1-Day 0.25% -1.97% 1.23%
1-Month -5.88% -16.21% -0.24%
1-Year -21.38% 10.32% 43.62%
3-Year CAGR 13.26% 12.99% 20.35%
5-Year CAGR 25.63% 30.46% 26.24%

* Compound Annual Growth Rate

Here are more details on the FREDUN PHARMA share price and the IND SWIFT LA share price.

Moving on to shareholding structures...

The promoters of FREDUN PHARMA hold a 48.9% stake in the company. In case of IND SWIFT LA the stake stands at 42.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FREDUN PHARMA and the shareholding pattern of IND SWIFT LA.

Finally, a word on dividends...

In the most recent financial year, FREDUN PHARMA paid a dividend of Rs 0.7 per share. This amounted to a Dividend Payout ratio of 2.1%.

IND SWIFT LA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of FREDUN PHARMA, and the dividend history of IND SWIFT LA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq Zomato to Enter Sensex | PVR Inox's Expansion Plan | Top Buzzing Stocks Todayeeq(Pre-Open)

Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.